Skip to content

Construction and effect of remote management platform for cancer-related fatigue in patients with nasopharyngeal carcinoma during chemoradiotherapy

Construction of remote symptom cluster management model for nasopharyngeal carcinoma patients in the post-epidemic era

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068300
Enrollment
Unknown
Registered
2023-02-14
Start date
2023-02-20
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

experimental group:Use an online platform to manage cancer-related fatigue
control group:In-hospital face to face guide of cancer-related fatigue

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the control group: 1. Patients with non-keratic nasopharyngeal carcinoma at stage I-IVa were diagnosed for the first time after histopathological examination (UICC/AJCC staging criteria, 2018, 8th Edition of Nasopharyngeal carcinoma); 2. Aged 18-64 years old; 3. Receiving simple radiotherapy; Intensity modulated conformal radiotherapy + concurrent chemotherapy; Induction chemotherapy + intensity modulated conformal radiotherapy + concurrent chemotherapy; 4. Karnofsky (KPS) score >= 70; 5. All the answers in the PAR-Q FORM are No. Inclusion criteria for study groups: 1. Patients with non-keratic nasopharyngeal carcinoma at stage I-IVa were diagnosed for the first time after histopathological examination (UICC/AJCC staging criteria for nasopharyngeal carcinoma, 2018 Edition 8); 2. Patients aged 18-64 years old were aware of their diagnosis and condition; 3. Receiving simple radiotherapy; Intensity modulated conformal radiotherapy + concurrent chemotherapy; Induction chemotherapy + intensity modulated conformal radiotherapy + concurrent chemotherapy; 4. Have certain reading and comprehension ability, no hearing impairment; 5. Karnofsky (KPS) score >= 70; 6. Answered no to all PAR-Q forms; 7. Long-term use of smart phones and personal wechat account; 8. Volunteer to join the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria for the control group were as follows: 1. There are cognitive or mental disorders or physical dysfunction; 2. Patients with other malignant tumors or bone metastases; 3. There are serious diseases of heart and brain, lung, blood vessel, liver and kidney function, such as heart disease, stroke, pulmonary insufficiency, thrombosis, etc.; 4. A history of severe endocrine and metabolic diseases, and a history of significant digestive system dysfunction; 5. Exercise records or cancer-related fatigue data were missing. Study group exclusion criteria are as follows: 1. Those with cognitive or mental disorders or physical dysfunction who cannot cooperate with the use of the platform or sports; 2. Patients with other malignant tumors or bone metastases; 3. There are serious diseases of heart and brain, lung, blood vessel, liver and kidney function, such as heart disease, stroke, pulmonary insufficiency, thrombosis, etc.; 4. A history of severe endocrine and metabolic diseases, and a history of significant digestive system dysfunction; 5. The doctor in charge thinks it is not suitable to participate in this researcher.

Design outcomes

Primary

MeasureTime frame
cancer-related fatigue;

Secondary

MeasureTime frame
exercise compliance;Nutriture;quality of life;exercise intensity;

Countries

China

Contacts

Public ContactJinsheng Hong

The First Affiliated Hospital of Fujian Medical University

hjs703@126.com+86 137 9937 5732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026